These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1135 related articles for article (PubMed ID: 26708045)
41. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma. Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368 [TBL] [Abstract][Full Text] [Related]
42. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis. Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997 [TBL] [Abstract][Full Text] [Related]
43. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition. Chow SM; Yau S; Kwan CK; Poon PC; Law SC Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761 [TBL] [Abstract][Full Text] [Related]
44. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach. Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305 [TBL] [Abstract][Full Text] [Related]
45. Prophylactic central lymph node dissection in cN0 papillary thyroid cancer: a comparative study of via breast and transoral approach versus via breast approach alone. Qiu R; Fu J Front Endocrinol (Lausanne); 2024; 15():1356739. PubMed ID: 38774230 [TBL] [Abstract][Full Text] [Related]
46. Association of adjuvant radioactive iodine therapy with survival in node-positive papillary thyroid cancer. Sun Y; Gong J; Guo B; Shang J; Cheng Y; Xu H Oral Oncol; 2018 Dec; 87():152-157. PubMed ID: 30527231 [TBL] [Abstract][Full Text] [Related]
47. Practice patterns among thyroid cancer surgeons: implications of performing a prophylactic central neck dissection. Deutschmann MW; Chin-Lenn L; Nakoneshny SC; Dort JC; Pasieka JL; Chandarana SP J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):55. PubMed ID: 27793192 [TBL] [Abstract][Full Text] [Related]
48. Lymphovascular invasion is associated with survival for papillary thyroid cancer. Pontius LN; Youngwirth LM; Thomas SM; Scheri RP; Roman SA; Sosa JA Endocr Relat Cancer; 2016 Jul; 23(7):555-62. PubMed ID: 27317633 [TBL] [Abstract][Full Text] [Related]
49. The presence of cancerous nodules in lymph nodes is a novel indicator of distant metastasis and poor survival in patients with papillary thyroid carcinoma. Chen L; Zhu Y; Zheng K; Zhang H; Guo H; Zhang L; Wu K; Kong L; Ruan W; Hu J; Zhang X; Chen X J Cancer Res Clin Oncol; 2017 Jun; 143(6):1035-1042. PubMed ID: 28204971 [TBL] [Abstract][Full Text] [Related]
50. Risk factors for central lymph node metastasis in papillary thyroid carcinoma: A National Cancer Data Base (NCDB) study. Suman P; Wang CH; Abadin SS; Moo-Young TA; Prinz RA; Winchester DJ Surgery; 2016 Jan; 159(1):31-9. PubMed ID: 26435436 [TBL] [Abstract][Full Text] [Related]
51. Risk factors and indication for dissection of right paraesophageal lymph node metastasis in papillary thyroid carcinoma. Zhang L; Liu H; Xie Y; Xia Y; Zhang B; Shan G; Li X Eur J Surg Oncol; 2016 Jan; 42(1):81-6. PubMed ID: 26615455 [TBL] [Abstract][Full Text] [Related]
52. Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer. Barczyński M; Konturek A; Stopa M; Nowak W Langenbecks Arch Surg; 2014 Feb; 399(2):237-44. PubMed ID: 24213969 [TBL] [Abstract][Full Text] [Related]
53. [Clinical application of carbon nanoparticles labeled lymph node in cervical lymph node dissection with papillary thyroid cancer staged preoperatively as N0]. Gao Q; Zhao D Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Dec; 28(24):1938-40. PubMed ID: 25895310 [TBL] [Abstract][Full Text] [Related]
54. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer. Sabet A; Binse I; Grafe H; Ezziddin S; Görges R; Poeppel TD; Bockisch A; Rosenbaum-Krumme SJ Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127 [TBL] [Abstract][Full Text] [Related]
55. Is Postoperative Adjuvant Radioactive Iodine Ablation Therapy Always Necessary for Intermediate-Risk Papillary Thyroid Cancer Patients With Central Neck Metastasis? Han K; Noh HM; Jeong HM; Lim YC Ann Surg Oncol; 2021 Nov; 28(12):7533-7544. PubMed ID: 34043093 [TBL] [Abstract][Full Text] [Related]
56. Long-term outcomes of central neck dissection for cN0 papillary thyroid carcinoma. Giordano D; Frasoldati A; Gabrielli E; Pernice C; Zini M; Castellucci A; Piana S; Ciarrocchi A; Cavuto S; Barbieri V Am J Otolaryngol; 2017; 38(5):576-581. PubMed ID: 28599790 [TBL] [Abstract][Full Text] [Related]
57. Prophylactic central lymph node dissection in cN0 patients with papillary thyroid carcinoma: A retrospective study in China. Xue S; Wang P; Liu J; Li R; Zhang L; Chen G Asian J Surg; 2016 Jul; 39(3):131-6. PubMed ID: 26117203 [TBL] [Abstract][Full Text] [Related]
58. Use of radioiodine after thyroid lobectomy in patients with differentiated thyroid cancer: does it change outcomes? Kiernan CM; Parikh AA; Parks LL; Solórzano CC J Am Coll Surg; 2015 Apr; 220(4):617-25. PubMed ID: 25667136 [TBL] [Abstract][Full Text] [Related]
59. Surgical extent of central lymph node dissection in clinically node-negative papillary thyroid cancer. Kim WW; Park HY; Jung JH Head Neck; 2013 Nov; 35(11):1616-20. PubMed ID: 23322499 [TBL] [Abstract][Full Text] [Related]
60. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma. Kim WW; Yang SI; Kim JH; Choi YS; Park YH; Kwon SK World J Surg Oncol; 2012 Oct; 10():226. PubMed ID: 23110552 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]